Olanzapine for the Treatment of Fibromyalgia Symptoms
Overview
Pharmacology
Psychiatry
Affiliations
Fibromyalgia is a chronic condition that is diagnosed primarily by the presence of generalized pain along with tenderness on palpation of certain body regions. Unfortunately, the pharmacological treatment of fibromyalgia remains problematic. Two patients are described who highlight the use of the atypical neuroleptic olanzapine for the control of symptoms related to fibromyalgia. Prior to the use of olanzapine, both patients had received a multitude of treatments, none of which greatly improved their ability to function in daily activities. With olanzapine, both patients reported a significant decrease in pain and marked improvement in daily functioning. In one case, the pain returned during a period of time when olanzapine was discontinued, an effect that was reversed when olanzapine was reintroduced. The paucity of serious side effects (i.e., extrapyramidal signs) with the atypical neuroleptic olanzapine strongly favors further exploration and use of this drug for the treatment of fibromyalgia symptoms.
Advances in diagnostic and treatment options in patients with fibromyalgia syndrome.
Gur A, Oktayoglu P Open Access Rheumatol. 2009; 1:193-209.
PMID: 27789991 PMC: 5074721. DOI: 10.2147/oarrr.s8040.
Olanzapine Attenuates Mechanical Allodynia in a Rat Model of Partial Sciatic Nerve Ligation.
Fukuda T, Yamashita S, Hisano S, Tanaka M Korean J Pain. 2015; 28(3):185-92.
PMID: 26175878 PMC: 4500782. DOI: 10.3344/kjp.2015.28.3.185.
Antipsychotics for acute and chronic pain in adults.
Seidel S, Aigner M, Ossege M, Pernicka E, Wildner B, Sycha T Cochrane Database Syst Rev. 2013; (8):CD004844.
PMID: 23990266 PMC: 10575602. DOI: 10.1002/14651858.CD004844.pub3.
The role of antipsychotics in the management of fibromyalgia.
Calandre E, Rico-Villademoros F CNS Drugs. 2012; 26(2):135-53.
PMID: 22296316 DOI: 10.2165/11597130-000000000-00000.
[Pharmacological treatment of fibromyalgia syndrome].
Sommer C, Hauser W, Berliner M, Bruckle W, Ehlers S, Monkemoller K Schmerz. 2008; 22(3):313-23.
PMID: 18458958 DOI: 10.1007/s00482-008-0676-2.